Literature DB >> 2494958

Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.

R A Asherson1, J Zulman, G R Hughes.   

Abstract

Procainamide is the commonest cause of a drug induced lupus syndrome. Long term administration of this compound may induce a variety of immunological abnormalities, including antinuclear antibodies. Uncommonly, 'lupus anticoagulants' have been demonstrated in the absence of other evidence of drug induced lupus. Details of a 67 year old man who developed not only drug induced lupus but also antiphospholipid antibodies which were associated with multiple pulmonary thromboemboli after the administration of procainamide are recorded.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494958      PMCID: PMC1003727          DOI: 10.1136/ard.48.3.232

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  33 in total

1.  Antinative DNA antibodies as a reaction to pyrazole drugs.

Authors:  M F Grayson; V M Martin; R L Markham
Journal:  Ann Rheum Dis       Date:  1975-08       Impact factor: 19.103

2.  Procainamide-induced antibodies to nucleoprotein, denatured and native DNA in human subjects.

Authors:  A Klajman; R Farkas; E Gold; S Ben-Efraim
Journal:  Clin Immunol Immunopathol       Date:  1975-03

3.  Hypocomplementemia in procainamide-associated systemic lupus erythematosus.

Authors:  P D Utsinger; N J Zvaifler; H G Bluestein
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

4.  Anti-DNA antibody in procainamide-induced lupus erythematosus. Determinations using DNA fractionated by methylated albumin-Kieselguhr chromatography.

Authors:  J B Winfield; J S Davis
Journal:  Arthritis Rheum       Date:  1974 Mar-Apr

5.  Hydralazine-induced Lupoid syndrome. Biochemical and immunological studies.

Authors:  N Blumenkrantz; A H Christiansen; S Ullman; G Asboe-Hansen
Journal:  Acta Med Scand       Date:  1974-06

6.  Natural antibodies to procaine amide.

Authors:  A S Russell; M Ziff
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

7.  Reactivity of anti-histone antibodies induced by procainamide and hydralazine.

Authors:  J P Portanova; R L Rubin; F G Joslin; V D Agnello; E M Tan
Journal:  Clin Immunol Immunopathol       Date:  1982-10

Review 8.  Drug-induced systemic lupus erythematosus: a critical review.

Authors:  S L Lee; P H CHase
Journal:  Semin Arthritis Rheum       Date:  1975-08       Impact factor: 5.532

9.  Hydralazine-induced lupus erythematosus-like syndrome.

Authors:  J J Irias
Journal:  Am J Dis Child       Date:  1975-07

10.  Procainamide-induced systemic lupus erythematosus. Renal involvement with deposition of immune complexes.

Authors:  T S Whittle; S K Ainsworth
Journal:  Arch Pathol Lab Med       Date:  1976-09       Impact factor: 5.534

View more
  5 in total

Review 1.  Drug-induced lupus anticoagulants and antiphospholipid antibodies.

Authors:  Jeffrey S Dlott; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

2.  Quinine induced lupus-like syndrome and cardiolipin antibodies.

Authors:  D Rosa-Re; F García; J Gascon; J Angrill; R Cervera
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

3.  Etanercept and venous thromboembolism: a case series.

Authors:  Ashima Makol; Madhusudan Grover; Carla Guggenheim; Houria Hassouna
Journal:  J Med Case Rep       Date:  2010-01-15

Review 4.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 5.  The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System.

Authors:  R Arreola-Diaz; A Majluf-Cruz; L E Sanchez-Torres; J Hernandez-Juarez
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.